🔴 Quantum BioPharma is trading 5.91% down in pre-market with no fresh company-specific catalyst identified

Quantum BioPharma is trading 5.91% down in pre-market at $3.50, with no fresh company-specific catalyst identified.

• No new overnight earnings, regulatory, financing, or corporate announcement was identified.
• It closed at $3.72 on September 17, 2026.
• Rodman & Renshaw initiated BUY coverage with a US$8 price target on September 17; the broader market is modestly higher, so the decline is not clearly market-driven.